SNF Prescription Drug Costs: When Admission Depends on the Family Bringing the Medication

When an SNF asks a family to supply an expensive medication, Part D billing can shift a drug cost already covered by the facility’s Part A payment. A nursing home pharmacy billing inquiry can therefore start before the resident arrives. The employee who heard the admission condition may know something that never appears on the drug claim.

The Family’s Promise Opened the Door

The Department of Health and Human Services Office of Inspector General described just such an admission in its October 2024 audit of Part D drug payments during covered SNF stays. Its account puts the family’s promise at the door:

The patient entered the facility on August 21, 2019, and left on September 16. During that covered Part A stay, the facility obtained a lung-cancer drug from the family and administered 27 tablets. Part D allowed payment totaling $15,494 for 30 tablets. The family’s delivery put the drug inside the facility while the payment went through Part D.

The facility told the auditors it did not know the family was using Part D to pay for the drug. It also said the hospital had struggled to find a placement because the medication was so expensive, and that the drug cost more than Medicare paid the facility for the entire stay. The admission condition made the family’s ability to supply a cancer drug part of whether the patient got a bed.

We see the absurdity in making the family solve a payment problem between healthcare businesses. The question for an insider is who understood how the drug would be obtained and paid for.

What Are the Medicare Billing Guidelines for Skilled Nursing Facility Care?

Medicare billing guidelines for skilled nursing facility care start with whether the resident has a covered Part A stay on the service date. Part A covers qualifying skilled care, with a daily payment that includes most services and the drugs ordinarily provided for the resident’s care and treatment. Under the Centers for Medicare & Medicaid Services billing reference, a prescription is not covered by Part D when Part A or Part B can pay for it.

Part A coverage can run out after 100 days in a benefit period while the resident remains in the facility. Part D coverage may then be available for a drug that otherwise qualifies.

The consolidated billing rules put responsibility for bundled services with the SNF, including most services an outside supplier provides. An outside supplier of a bundled service bills the facility. Drug coverage reaches beyond what the facility routinely stocks to medication obtained from an outside pharmacy. Some drugs, including certain chemotherapy drugs, have separate Part B coverage, so the particular medication matters alongside the dates. Under today’s Patient Driven Payment Model, the facility still has to cover drugs included in its Part A payment.

The Records That Connect Admission to the Drug Claim

The admission request, coverage dates, medication administration record and pharmacy claim describe different parts of the same transaction. Connecting them shows who supplied the drug, whether the facility administered it during covered care and which payer bore the cost. The auditors used physician orders, administration records and pharmacy shipping and delivery records to examine that connection.

The usual purchasing relationship helps explain why the family-supply arrangement stands out. The audit describes long-term-care pharmacies as typically owned by nursing homes or contracted to supply them. Specialty pharmacies provide more complex medications for serious conditions. In 34 of the 36 specialty-pharmacy sample items with documented administration during covered stays, residents or families supplied the drugs to the facilities.

For an admissions employee, the important detail may be the promise required before acceptance. For the pharmacy employee, it may be how that promise turned into a dispensing transaction billed to Part D.

The pharmacy claim also feeds another record. The drug plan sends Medicare’s administrators a prescription drug event record summarizing the drug, service date, pharmacy, payment and patient residence information. The agency uses those records in calculating payments to plans. The facility’s administration record and the plan’s payment data therefore connect health care inside the building to federal money outside it.

Later corrections matter to that connection. In its response to the audit, the Centers for Medicare & Medicaid Services explained that a plan must submit a deletion record when a prescription already reported to Part D belonged under Part A. We examine the original transaction alongside later adjustments, deletions or payment changes. That is how the inquiry reaches what ultimately remained charged to the drug benefit.

When Refills Continue While the Skilled Nursing Facility Supplies the Drug

The Inspector General also found a different problem: another pharmacy kept dispensing medication while the SNF supplied the resident’s treatment. In one example, the facility obtained HIV drugs from its contracted pharmacy and administered them during the covered stay. Another pharmacy dispensed the same drugs, generating Part D costs. The auditors found no documentation showing that the other pharmacy’s supply was administered at the SNF.

A second example involved retail pharmacy fills for drugs missing from the facility’s physician orders and medication administration records. The facility’s delivery sheets identified a different pharmacy for other drugs it obtained and administered. Here the useful comparison is the continuing refill history against the actual facility supply. It raises a different operational question from an admission conditioned on the family bringing medication: why did those outside fills continue while the resident was receiving covered care?

How Much Part D Paid for Drugs the Skilled Nursing Facility Owed

The Inspector General examined transactions from 2018 through 2020 and estimated that up to $465.1 million in Part D costs were improperly paid for drugs available under the Part A SNF benefit. Within that amount, it estimated approximately $245.4 million for drugs that medical records showed were administered during covered stays.

The estimated costs included approximately $21 million paid by Part D enrollees for drugs available under the Part A benefit. Patients were paying out of pocket for medication that Medicare’s facility payment already covered.

Medicare’s administrators argued that the audit needed proof the drugs were actually given during covered stays. The Inspector General stood by its finding that Part D coverage turns on whether Part A or Part B payment was available for the prescribed and dispensed drug. For an insider, the disagreement makes the intended use, dispensing date and administration record especially valuable.

The administrators also described medication intended for use after discharge that was used inside the facility because the discharge plan changed. That example shows why the dispensing date needs to be read alongside the drug’s intended use and the actual stay.

The audit also describes a gap between the information facilities held and what drug plans could see. Plan sponsors said they lacked reliable, timely covered-stay dates, and some said facilities did not always cooperate when asked for them. Residence codes on pharmacy claims did not reliably identify Part A coverage.

During the audit period, the daily Transaction Reply Report that Medicare’s administrators sent plans identified hospice status but omitted Part A SNF stay status. Sponsors told the auditors that daily covered-stay information would make it feasible to apply a point-of-sale edit to pharmacy claims. The gap helps explain why an accepted drug claim could coexist with a covered facility stay.

The Centers for Medicare & Medicaid Services returned to the drug-payment issue in its December 11, 2025 newsletter. It directed facilities to the billing reference to identify when prescription drugs belong under Part A instead of the resident’s Part D plan. An employee who knows when the facility learned of the coverage or the payer claim can connect that guidance to the decisions inside the business.

What an Insider Can Add

An admissions employee may know who approved acceptance on the family’s assurance. A nurse may know which supply was administered. Pharmacy and claims staff may know the dispensing history, payer response and later correction. Together, those accounts can show how an admission decision became a government-paid drug transaction.

We connect that inside knowledge to what reached the payer and who controlled the decision. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The starting point here is specific: what the family was asked to supply, what the facility used and who knew where the bill went.

When You Know Why the Family Brought the Drug

If you know a facility made admission depend on a family supplying medication, speak with our whistleblower experts about the request and the drug bill. We help you build your strongest nursing home whistleblower case around the admission decision, the care and the public money, and bring in nursing-home pharmacy whistleblower lawyers who understand Medicare billing. We stay beside you from the first call through the case, bringing our experience to the decisions ahead.